Publicacions en col·laboració amb investigadors/es de Instituto de Investigación Biomédica de Salamanca (10)

2019

  1. Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia

    Leukemia, Vol. 33, Núm. 1, pp. 249-278

2018

  1. Lmo2 expression defines tumor cell identity during T-cell leukemogenesis

    EMBO Journal, Vol. 37, Núm. 14

  2. Loss of Pax5 exploits sca1-BCR-ABLp190 susceptibility to confer the metabolic shift essential for pB-ALL

    Cancer Research, Vol. 78, Núm. 10, pp. 2669-2679

2017

  1. Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice

    Blood, Vol. 129, Núm. 19, pp. 2645-2656

  2. Infection exposure promotes ETV6-RUNX1 precursor B-cell leukemia via impaired H3K4 demethylases

    Cancer Research, Vol. 77, Núm. 16, pp. 4365-4377

2016

  1. Could vitamin d analogues be used to target leukemia stem cells?

    International Journal of Molecular Sciences, Vol. 17, Núm. 6

2015

  1. Infection exposure is a causal factor in B-cell precursor acute lymphoblastic leukemia as a result of Pax5-inherited susceptibility

    Cancer Discovery, Vol. 5, Núm. 12, pp. 1328-1343

2014

  1. Early epigenetic cancer decisions

    Biological Chemistry, Vol. 395, Núm. 11, pp. 1315-1320

  2. Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma

    Nature Communications, Vol. 5

2013

  1. Genetic background affects susceptibility to tumoral stem cell reprogramming

    Cell Cycle, Vol. 12, Núm. 15, pp. 2505-2509